Rose McGowan

Articles

Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Study lungs ©pascalkphoto/stock.adobe.com

Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Trial

May 22nd 2023

Findings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.

Latest Updated Articles

Published: June 15th 2013 | Updated: March 15th 2025

Scaly Plaque on the Nose

Published: April 13th 2016 | Updated: March 15th 2025

A 13-year-old Girl with a Vesicular Rash on Palms

Published: December 6th 2013 | Updated: March 15th 2025

Another Non-Melanoma Skin Cancer?

Published: March 12th 2025 | Updated: March 15th 2025

Early-Onset Atopic Dermatitis Significantly Impacts Psychosocial Development, Wellbeing Throughout Adult Life

Published: August 6th 2019 | Updated: March 15th 2025

Image IQ: Recurrent Eyelid Purpura

Published: February 10th 2016 | Updated: March 15th 2025

A Friable Lesion on the Neck of a 15-year-old Boy: Dx?

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777